Merck Once-Daily HIV Treatment Idvynso Approved by FDA
|
Its indication covers adults with HIV-1 infection—the most
common and virulent strain of HIV—and replaces current antiretroviral
regimens. FDA ... |
Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection
A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection. View article...